What We Do

What do your doctors actually believe — and is it changing?

Access AI-moderated interviews from 1 million+ global specialists, turned into an always-on intelligence layer your commercial teams can interrogate and verify.

  • Discover the truth through deep, scalable doctor research
  • Move truth to where work happens with self-serve, evidence-linked tools
  • Prove the truth changed something by tracking how beliefs evolve over time

The WHY behind doctor beliefs at scale

We conduct in-depth conversations with specialists to understand not just what doctors do — but why, and what would change their minds.

Oncologists · Rare disease specialists · KOLs · Prescribers

Treatment beliefs & decision logic

The reasoning behind prescribing choices, not just the choices themselves

Barriers, concerns & trade-offs

What holds doctors back, and what would overcome those barriers

Competitive perceptions & positioning

How your brand lands relative to alternatives in the doctor's mind

Real-world prescribing patterns

Actual treatment decisions, patient journeys, and line-of-therapy logic

Key capabilities

  • Adaptive conversations
    Questions that follow the clinician's own reasoning, not a rigid survey script
  • Designed for scale
    Hundreds to thousands of specialists per study — e.g. 600 oncologists across 8 markets
  • Global reach
    Multi-market coverage across EU, US, APAC and emerging markets simultaneously
  • Unmet needs & knowledge gaps
    Surface what doctors wish they knew — and where your brand can credibly fill the gap
What we do

What MediSights Does

MediSights helps life sciences commercial teams capture and interact with high-value qualitative insights at scale. With AI-driven workflows, we are rebuilding market research beyond static reports in a way that is compliant, traceable and purpose-built for specialty care.

Generic research platforms were not built for this. MediSights is.

Insights that compound

Most market research gives you a snapshot. MediSights gives you insights that evolve over time.

Track how physician beliefs, competitive perceptions, and prescribing intentions shift wave over wave. See whether your brand investments are actually moving the needle — before the next sales cycle.

Physician confidence in Agent X — Wave 1 → Wave 5
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Positive sentiment
Neutral / uncertain

From raw conversations to queryable intelligence

MediSights — Insight Explorer
"What are oncologists' from northern england main objections to Agent X in second-line, and how have they shifted since Q3?"
AI synthesis · 214 interviews
Biomarker uncertainty remains the primary barrier (cited by 67% of respondents), though confidence has improved significantly since Q3 following ASCO data — down from 81%. Reimbursement pathway concerns have overtaken OS data doubts as the second-ranked barrier in Q4, particularly among community oncologists.
Source evidence — tap to verify
"My hesitation is less about the efficacy now — the ASCO data moved me — it's more about whether my patients will actually get access in a reasonable timeframe..."
Oncologist · Hamburg · Wave 4 interview · November 2024

Real-time organisation

Conversations automatically structured by market, specialty, line of therapy, and competitive landscape — no manual tagging or analyst bottleneck

Natural language queries

Your teams ask questions in plain English and get answers instantly. Multi-market comparisons, trend analysis, segment cuts — on demand

Self-serve exploration

No analyst queue. Brand leads, medical affairs, and commercial teams interrogate the data themselves — in the moment they need it

The trust feature

Every insight is grounded in evidence. We show you the underlying doctor quotes and data — no black-box outputs, no hallucinations on clinical facts

Purpose built for life science

Pharma compliance isn't a feature. It's the foundation.

Generic AI tools weren't built for life sciences. MediSights is. Every layer — from interview design to insight delivery — meets pharma's strictest requirements. Not bolted on after the fact.

Adverse event detection & routing
Full audit trails
GDPR & data privacy
Pharma-grade security
BHBIA compliant
EPHMRA member
Clinical ontology grounding
No hallucinations on clinical facts

Insights that plug into how you already operate

Brand strategy & cycle planning
Positioning, messaging, segmentation — grounded in what doctors actually believe, not what you hope they believe
Field execution & MSL conversations
Territory planning, objection handling — backed by real doctor language and real-world concerns
Medical affairs
Evidence gaps, KOL perception, unmet medical needs — surfaced and verified from primary research
Analytics & competitive intelligence
Longitudinal tracking, multi-market comparisons, sentiment shift — feeding your existing BI infrastructure
CRM & next-best-action
Veeva CRM
Salesforce
Analytics & BI stacks
Existing Cloud Platforms
Data warehouses

"We don't replace your systems. We feed them with better doctor intelligence."

Still working from static decks and outdated surveys?

Deep, qualitative market intelligence at scale — built for oncology and rare diseases, formatted for how pharma actually works.